Market Cap 310.76M
Revenue (ttm) 14.20M
Net Income (ttm) -49.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -349.23%
Debt to Equity Ratio -2.69
Volume 414,166
Avg Vol 987,294
Day's Range N/A - N/A
Shares Out 82.65M
Stochastic %K 42%
Beta 0.59
Analysts Strong Sell
Price Target $10.55

Company Profile

Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types of therapies for additional ophthalmic disorders. It develops OPGx-LCA5, an early-onset retinal degeneration that is in Phase 1/2 clinical trial for the treatment of LCA5-associated IRD; and OPGx-BEST1 to treat BEST1-associated retinal disease. The company also develops various pre-clinical IRD programs...

Industry: Biotechnology
Sector: Healthcare
Phone: 984 884 6030
Website: opusgtx.com
Address:
8 Davis Drive, Suite 220, Durham, United States
signaljumper
signaljumper Aug. 12 at 9:45 AM
$IRD lets do the 4$ JUMP
0 · Reply
signaljumper
signaljumper Aug. 11 at 8:02 PM
$IRD new Stockreport. Upcoming catalysts, deep dive into the fundamental Data und Chart Updates. Sign in for free https://www.patreon.com/posts/166171957?utm_campaign=postshare_creator&utm_content=android_share&utm_source=twitter
0 · Reply
signaljumper
signaljumper Aug. 9 at 8:42 AM
$IRD Opus Genetics Full Stock Report Sign in for free to unlock the full company deep dive, valuation & chart analysis. 👉 Read the full report. https://www.patreon.com/signaljumper/posts/ird-opus-inc-09-166171957?utm_medium=social&utm_source=twitter&utm_campaign=postshare_creator&utm_content=join_link
1 · Reply
prismmarketview
prismmarketview Aug. 8 at 5:24 PM
August 8 is International Ophthalmology Day. This day celebrates ophthalmologists who dedicate their expertise to protecting one of our most valuable senses. $IRD, $HROW, $OKYO, $BLTE, $OCUL
0 · Reply
TheAliAbdul
TheAliAbdul Aug. 6 at 10:44 AM
$IRD earnings this week?
0 · Reply
signaljumper
signaljumper Aug. 4 at 10:29 AM
$IRD at the Moment we are in a downtrend Chanel. So a Close above 4$ and we broker Out . Lets get IRD bullish again. Oktober Data readout
1 · Reply
TheAliAbdul
TheAliAbdul Aug. 3 at 10:43 PM
$IRD other Boitechs seem to rocket 100% after the slightest good news atm, hope we get our day in September.
0 · Reply
signaljumper
signaljumper Jul. 30 at 9:46 PM
$IRD load the boat 4.50$ Close above and we will See nee 52 week highs very soon
0 · Reply
BiotechButterflies
BiotechButterflies Jul. 30 at 9:36 PM
$IRD ... a fast recovery last few days.... seemed strange when dipped below $4 and even stranger when approached $3.... had me wondering if I missed something... these folks just keep rolling and rolling good stuff...
0 · Reply
BiotechSheff
BiotechSheff Jul. 30 at 7:21 PM
$IRD ..$3.80 … solid catalyst here w/ it being 2nd week of September . Solid move today!
0 · Reply
Latest News on IRD
Opus Genetics Registration statement: Registration filing

Aug 7, 2026, 8:00 AM EDT - 7 days ago

Opus Genetics Registration statement: Registration filing


Opus Genetics files $300M mixed securities shelf

2026-08-07T10:25:56.000Z - 7 days ago

Opus Genetics files $300M mixed securities shelf


Opus Genetics reports Q2 EPS (14c), consensus (16c)

2026-08-06T11:20:54.000Z - 8 days ago

Opus Genetics reports Q2 EPS (14c), consensus (16c)


Opus Genetics Earnings release: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 8 days ago

Opus Genetics Earnings release: Q2 2026


Opus Genetics Quarterly report: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 8 days ago

Opus Genetics Quarterly report: Q2 2026


Opus Genetics enrolls last patient in OPGx-LCA5 trial

2026-08-03T11:50:12.000Z - 11 days ago

Opus Genetics enrolls last patient in OPGx-LCA5 trial


Opus Genetics initiated with a Buy at TD Cowen

2026-07-29T09:35:19.000Z - 16 days ago

Opus Genetics initiated with a Buy at TD Cowen


Opus Genetics announces FDA alignment on OPGx-LCA5 trial

2026-07-06T11:10:18.000Z - 5 weeks ago

Opus Genetics announces FDA alignment on OPGx-LCA5 trial


Opus Genetics initiated with an Outperform at RBC Capital

2026-06-23T11:14:14.000Z - 7 weeks ago

Opus Genetics initiated with an Outperform at RBC Capital


Opus Genetics assumed with a Buy at Chardan

2026-06-18T00:25:07.000Z - 2 months ago

Opus Genetics assumed with a Buy at Chardan


Opus Genetics Transcript: R&D Day 2026

Jun 16, 2026, 10:00 AM EDT - 2 months ago

Opus Genetics Transcript: R&D Day 2026


Opus Genetics Slides: FY 2026

Jun 16, 2026, 10:00 AM EDT - 2 months ago

Opus Genetics Slides: FY 2026


Opus Genetics management to meet with BTIG

2026-06-12T17:40:25.000Z - 2 months ago

Opus Genetics management to meet with BTIG


Opus Genetics Registration statement: Registration filing

Jun 5, 2026, 8:00 AM EDT - 2 months ago

Opus Genetics Registration statement: Registration filing


Opus Genetics initiated with a Buy at Guggenheim

2026-06-04T10:16:57.000Z - 2 months ago

Opus Genetics initiated with a Buy at Guggenheim


Opus Genetics management to meet with Citizens

2026-06-03T17:55:11.000Z - 2 months ago

Opus Genetics management to meet with Citizens


Opus Genetics Slides: Investor presentation

May 30, 2026, 7:00 AM EDT - 2 months ago

Opus Genetics Slides: Investor presentation


Opus Genetics initiated with an Outperform at Leerink

2026-05-21T10:33:45.000Z - 3 months ago

Opus Genetics initiated with an Outperform at Leerink


Opus Genetics initiated with an Outperform at Leerink

2026-05-21T10:17:22.000Z - 3 months ago

Opus Genetics initiated with an Outperform at Leerink


Opus Genetics Slides: Corporate presentation

May 17, 2026, 7:00 AM EDT - 3 months ago

Opus Genetics Slides: Corporate presentation


Opus Genetics price target lowered to $11 from $12 at Citizens

2026-05-13T09:57:18.000Z - 3 months ago

Opus Genetics price target lowered to $11 from $12 at Citizens


Opus Genetics reports Q1 EPS (75c), consensus (14c)

2026-05-12T12:00:32.000Z - 3 months ago

Opus Genetics reports Q1 EPS (75c), consensus (14c)


Opus Genetics Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 3 months ago

Opus Genetics Quarterly report: Q1 2026


Opus Genetics Registration statement: Registration filing

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Opus Genetics Registration statement: Registration filing


Opus Genetics Proxy statement: Proxy filing

Mar 23, 2026, 8:00 AM EDT - 5 months ago

Opus Genetics Proxy statement: Proxy filing


Opus Genetics Slides: Corporate presentation

Mar 16, 2026, 7:11 PM EDT - 5 months ago

Opus Genetics Slides: Corporate presentation


Opus Genetics Registration statement: Registration filing

Mar 13, 2026, 8:00 AM EDT - 5 months ago

Opus Genetics Registration statement: Registration filing


Opus Genetics Proxy statement: Proxy filing

Mar 12, 2026, 8:00 AM EDT - 5 months ago

Opus Genetics Proxy statement: Proxy filing


Opus Genetics Earnings release: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Opus Genetics Earnings release: Q4 2025


Opus Genetics Annual report: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Opus Genetics Annual report: Q4 2025


Opus Genetics Announces $25 Million Private Placement

Feb 13, 2026, 7:30 AM EST - 6 months ago

Opus Genetics Announces $25 Million Private Placement


Opus Genetics to Participate in Upcoming Investment Conferences

Nov 20, 2025, 8:00 AM EST - 9 months ago

Opus Genetics to Participate in Upcoming Investment Conferences


Opus Genetics Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Opus Genetics Earnings release: Q3 2025


Opus Genetics Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Opus Genetics Quarterly report: Q3 2025


Opus Genetics Announces $23 Million Registered Direct Offering

Nov 6, 2025, 7:00 AM EST - 10 months ago

Opus Genetics Announces $23 Million Registered Direct Offering


Opus Genetics Transcript: Study result

Sep 30, 2025, 8:30 AM EDT - 11 months ago

Opus Genetics Transcript: Study result


Opus Genetics Press release: Study result

Sep 30, 2025, 8:30 AM EDT - 11 months ago

Opus Genetics Press release: Study result


Opus Genetics Slides: Study result

Sep 30, 2025, 8:30 AM EDT - 11 months ago

Opus Genetics Slides: Study result


Opus Genetics Appoints Rob Gagnon as Chief Financial Officer

Sep 2, 2025, 8:00 AM EDT - 1 year ago

Opus Genetics Appoints Rob Gagnon as Chief Financial Officer


Opus Genetics Earnings release: Q2 2025

Aug 13, 2025, 7:00 AM EDT - 1 year ago

Opus Genetics Earnings release: Q2 2025


Opus Genetics Quarterly report: Q2 2025

Aug 13, 2025, 7:00 AM EDT - 1 year ago

Opus Genetics Quarterly report: Q2 2025


Opus Genetics Transcript: Investor update

Jun 26, 2025, 8:00 AM EDT - 1 year ago

Opus Genetics Transcript: Investor update


Opus Genetics Press release: Investor update

Jun 26, 2025, 8:00 AM EDT - 1 year ago

Opus Genetics Press release: Investor update


signaljumper
signaljumper Aug. 12 at 9:45 AM
$IRD lets do the 4$ JUMP
0 · Reply
signaljumper
signaljumper Aug. 11 at 8:02 PM
$IRD new Stockreport. Upcoming catalysts, deep dive into the fundamental Data und Chart Updates. Sign in for free https://www.patreon.com/posts/166171957?utm_campaign=postshare_creator&utm_content=android_share&utm_source=twitter
0 · Reply
signaljumper
signaljumper Aug. 9 at 8:42 AM
$IRD Opus Genetics Full Stock Report Sign in for free to unlock the full company deep dive, valuation & chart analysis. 👉 Read the full report. https://www.patreon.com/signaljumper/posts/ird-opus-inc-09-166171957?utm_medium=social&utm_source=twitter&utm_campaign=postshare_creator&utm_content=join_link
1 · Reply
prismmarketview
prismmarketview Aug. 8 at 5:24 PM
August 8 is International Ophthalmology Day. This day celebrates ophthalmologists who dedicate their expertise to protecting one of our most valuable senses. $IRD, $HROW, $OKYO, $BLTE, $OCUL
0 · Reply
TheAliAbdul
TheAliAbdul Aug. 6 at 10:44 AM
$IRD earnings this week?
0 · Reply
signaljumper
signaljumper Aug. 4 at 10:29 AM
$IRD at the Moment we are in a downtrend Chanel. So a Close above 4$ and we broker Out . Lets get IRD bullish again. Oktober Data readout
1 · Reply
TheAliAbdul
TheAliAbdul Aug. 3 at 10:43 PM
$IRD other Boitechs seem to rocket 100% after the slightest good news atm, hope we get our day in September.
0 · Reply
signaljumper
signaljumper Jul. 30 at 9:46 PM
$IRD load the boat 4.50$ Close above and we will See nee 52 week highs very soon
0 · Reply
BiotechButterflies
BiotechButterflies Jul. 30 at 9:36 PM
$IRD ... a fast recovery last few days.... seemed strange when dipped below $4 and even stranger when approached $3.... had me wondering if I missed something... these folks just keep rolling and rolling good stuff...
0 · Reply
BiotechSheff
BiotechSheff Jul. 30 at 7:21 PM
$IRD ..$3.80 … solid catalyst here w/ it being 2nd week of September . Solid move today!
0 · Reply
gumby361
gumby361 Jul. 27 at 8:52 PM
$IRD ramping up again
0 · Reply
JussieLivermore
JussieLivermore Jul. 24 at 1:53 PM
$IRD Adding, expecting support around AVWAP from all time lows $2.83
1 · Reply
TheAliAbdul
TheAliAbdul Jul. 24 at 10:59 AM
$IRD will look to buy back in between $2.30-$2.60 think it’s will bottom out in that area.
1 · Reply
JussieLivermore
JussieLivermore Jul. 23 at 3:39 PM
$IRD Picking up shares in low $2.90's
0 · Reply
TheAliAbdul
TheAliAbdul Jul. 16 at 2:41 PM
$IRD trying to figure out where would be appropriate to buy back in, seems to break through every support level.
0 · Reply
WolfOf_MyStreet
WolfOf_MyStreet Jul. 14 at 6:28 PM
$IRD looks like it wants to bounce off the 200 day MA.
0 · Reply
TheAliAbdul
TheAliAbdul Jul. 10 at 2:09 PM
$IRD company blackout on news till middle of September, might as well switch this board off till then
1 · Reply
signaljumper
signaljumper Jul. 1 at 7:52 PM
$IRD Hit the area in the downside. Now we bulid a floor for the next upmove Key is the orange Line a Break above 4.68 and we will See the next Leg Up. Targets marked Green in the Chart.
0 · Reply
Um8a123
Um8a123 Jun. 30 at 12:38 AM
$IRD it’s gonna blow any of these day!
0 · Reply
signaljumper
signaljumper Jun. 29 at 4:59 PM
$IRD WE only need some Volume then we will move north
0 · Reply
OnlyFibs
OnlyFibs Jun. 27 at 10:16 PM
Effective 6/29 ~$12.2T in assets now tracking these names: $ZN — AI at the intersection of insurance & mobility. Joins Russell 2000 + 3000 after strong traction in underwriting & fleet safety $ZENA — Tech play added to the Russell 3000, opening the door to massive institutional index exposure $IRD — Gene therapy for inherited retinal diseases. Added to Russell 2000, 3000 & Microcap — big liquidity unlock for a small biotech $ALOY — Specialty alloys producer entering the Russell 3000 as an institutional visibility catalyst
0 · Reply
JodieChristy
JodieChristy Jun. 27 at 3:24 PM
The annual Russell Index reconstitution takes effect on June 29, driving passive flows across roughly $12.2T in tracking assets. Key component additions to monitor for volume changes include: $ZN joining the Russell 2000 and 3000; $ZENA added to the Russell 3000; $IRD added to the Russell 2000, 3000, and Microcap; $ALOY entering the Russell 3000; and $FJET joining the Russell 3000 within 7 months of its listing. Institutional inflows and volume shifts on these small caps will be a primary focus.
0 · Reply